All other professional, scientific and technical activities n.e.c.
LØDØEN PHARMA AS
Revenue 2025
NOK 20,000
Operating profit
NOK −13,000
Equity
NOK −8,000
Incorporated
2023
Share capital
NOK 30,000
Key figures · 2025
Current ratio
0.09
Equity ratio
-1042.6%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -66.1% | |
| Net margin (%%) | -66.1% | |
| Return on assets (%%) | -1758.2% | |
| Likviditet | ||
| Current ratio | 0.09 | |
| Working capital | −8k | |
| Soliditet | ||
| Equity ratio (%%) | -1042.6% | |
| Debt-to-equity ratio | -1.10 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.